Exponent, Inc. filed its quarterly report on Form 10-Q with the SEC on November 6, 2026, covering the fiscal quarter and nine-month period ended October 2, 2026, reporting growth in revenues and net income compared to the prior-year periods.

Key Highlights

  • Nine-month revenues: Total revenues reached $511,648 thousand for the nine months ended October 2, 2026, up from $434,589 thousand in the comparable prior-year period, according to the filing.
  • Third-quarter net income: Net income for the three months ended October 2, 2026 was $30,943 thousand, compared with $28,044 thousand for the three months ended October 3, 2025.
  • Nine-month net income: Net income for the nine-month period was $89,907 thousand, up from $81,247 thousand a year earlier.
  • Diluted EPS: Diluted earnings per share were $0.64 for the third quarter and $1.83 for the nine-month period, versus $0.55 and $1.58, respectively, in the prior-year periods.
  • Treasury stock activity: The company purchased treasury shares totaling $147,468 thousand during the nine months ended October 2, 2026, with 18,154 thousand shares held in treasury at period end.
  • Cash dividend declared: Cash dividends declared per common share were $0.31 for the third quarter and $0.93 for the nine-month period, compared with $0.30 and $0.90 in the prior-year periods.
  • Shares outstanding: As of October 30, 2026, the registrant had 47,552,453 shares of common stock outstanding.

Exponent's Engineering and Scientific Consulting Operations: Third-Quarter and Year-to-Date Financial Results

Exponent, Inc. (NASDAQ:EXPO), a Menlo Park, California-based engineering and scientific consulting firm, reported that revenues before reimbursements for the third quarter ended October 2, 2026 were $153,063 thousand, rising from $137,073 thousand in the third quarter of the prior year. For the nine-month period, revenues before reimbursements were $453,740 thousand, compared with $407,378 thousand a year earlier. The company provides expert consulting across engineering, science, and regulatory disciplines, with client billings captured both as direct consulting fees and as reimbursed expenses.

Operating income for the three months ended October 2, 2026 was $41,877 thousand, compared with $29,038 thousand for the same period a year prior. For the nine months, operating income was $111,278 thousand versus $90,647 thousand. Total operating expenses for the nine-month period were $400,370 thousand, with compensation and related expenses representing the largest component at $282,018 thousand. The filing noted that total other income, net, declined to $1,116 thousand for the third quarter from $9,579 thousand a year earlier, as interest income, net, fell to $668 thousand from $2,312 thousand and miscellaneous income, net, declined to $448 thousand from $7,267 thousand.

On the balance sheet, cash and cash equivalents stood at $114,689 thousand as of October 2, 2026, down from $221,930 thousand at January 2, 2026, a change the filing attributes in part to $147,468 thousand in treasury share purchases during the nine-month period. Accounts receivable, net, increased to $211,412 thousand from $181,507 thousand at the prior fiscal year-end. Total stockholders' equity was $307,886 thousand at October 2, 2026, compared with $390,341 thousand at January 2, 2026. The company disclosed that 65,707 thousand shares of common stock were issued at both period-end dates, with par value of $0.001 per share.

What Was Disclosed

Exponent, Inc. disclosed its unaudited condensed consolidated financial results for the fiscal quarter and nine-month period ended October 2, 2026, including income statements, balance sheets, statements of comprehensive income, stockholders' equity changes, and related notes.